Home  >  Products  >  CLEC14A (C-type lectin domain family 14, member A ) Blocking Peptide (the C terminal of CLEC14A)(100ug)
CLEC14A (C-type lectin domain family 14, member A ) Blocking Peptide (the C terminal of CLEC14A)(100ug)

CLEC14A (C-type lectin domain family 14, member A ) Blocking Peptide (the C terminal of CLEC14A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CLEC14A Antibody (ARP68222_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP68222
Size: 100ug
Weight: 54kDa
Gene: 161198
Format: Lyophilized powder
Target: This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting.
Alternative names: C14orf27; CEG1; EGFR-5
See Full Product Listings >